These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 21914806)
1. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806 [TBL] [Abstract][Full Text] [Related]
2. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis. Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774 [TBL] [Abstract][Full Text] [Related]
3. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth. Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072 [TBL] [Abstract][Full Text] [Related]
4. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272 [TBL] [Abstract][Full Text] [Related]
5. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin. Matou-Nasri S; Gaffney J; Kumar S; Slevin M Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912 [TBL] [Abstract][Full Text] [Related]
7. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells. Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615 [TBL] [Abstract][Full Text] [Related]
8. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. Lokeshwar VB; Selzer MG J Biol Chem; 2000 Sep; 275(36):27641-9. PubMed ID: 10882722 [TBL] [Abstract][Full Text] [Related]
9. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. Hall CL; Wang C; Lange LA; Turley EA J Cell Biol; 1994 Jul; 126(2):575-88. PubMed ID: 7518470 [TBL] [Abstract][Full Text] [Related]
12. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds. Tolg C; Hamilton SR; Zalinska E; McCulloch L; Amin R; Akentieva N; Winnik F; Savani R; Bagli DJ; Luyt LG; Cowman MK; McCarthy JB; Turley EA Am J Pathol; 2012 Oct; 181(4):1250-70. PubMed ID: 22889846 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronate receptors mediating glioma cell migration and proliferation. Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065 [TBL] [Abstract][Full Text] [Related]
15. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2. Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782 [TBL] [Abstract][Full Text] [Related]
17. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. Tolg C; Hamilton SR; Nakrieko KA; Kooshesh F; Walton P; McCarthy JB; Bissell MJ; Turley EA J Cell Biol; 2006 Dec; 175(6):1017-28. PubMed ID: 17158951 [TBL] [Abstract][Full Text] [Related]
18. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. Kim Y; Lee YS; Choe J; Lee H; Kim YM; Jeoung D J Biol Chem; 2008 Aug; 283(33):22513-28. PubMed ID: 18577517 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ. Park D; Kim Y; Kim H; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Jeon J; Choi C; Kim YM; Jeoung D Mol Cells; 2012 Jun; 33(6):563-74. PubMed ID: 22610405 [TBL] [Abstract][Full Text] [Related]
20. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation. Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]